{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:16:40Z","timestamp":1747196200478,"version":"3.40.5"},"reference-count":18,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005737","name":"UPMC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005737","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>We performed whole genome sequencing on SARS-CoV-2 from 59 vaccinated individuals from southwest Pennsylvania who tested positive between February and September, 2021. A comparison of mutations among vaccine breakthrough cases to a time-matched control group identified potential adaptive responses of SARS-CoV-2 to vaccination.<\/jats:p>","DOI":"10.1371\/journal.pone.0272954","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T17:34:04Z","timestamp":1661967244000},"page":"e0272954","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genomic characterization of SARS-CoV-2 from vaccine breakthrough cases in Allegheny County, Pennsylvania"],"prefix":"10.1371","volume":"17","author":[{"given":"Kady D.","family":"Waggle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa P.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7726-0765","authenticated-orcid":true,"given":"Vaughn S.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vatsala","family":"Srinivasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tung","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5562-8880","authenticated-orcid":true,"given":"Graham M.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria","family":"Van Tyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee H.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8271-651X","authenticated-orcid":true,"given":"Jane W.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,8,31]]},"reference":[{"key":"pone.0272954.ref001","article-title":"Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study","author":"PY Chia","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"pone.0272954.ref002","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"JS Tregoning","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"18","key":"pone.0272954.ref003","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152702","article-title":"Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City","volume":"131","author":"R Duerr","year":"2021","journal-title":"J Clin Invest"},{"key":"pone.0272954.ref004","article-title":"The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity","author":"SD Pollett","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"7883","key":"pone.0272954.ref005","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion","volume":"599","author":"P Mlcochova","year":"2021","journal-title":"Nature"},{"key":"pone.0272954.ref006","article-title":"Omicron is supercharging the COVID vaccine booster debate","author":"E. Dolgin","year":"2021","journal-title":"Nature"},{"key":"pone.0272954.ref007","article-title":"Improvements to the ARTIC multiplex PCR method for SARS-CoV-2","author":"JR Tyson","year":"2020","journal-title":"genome sequencing using nanopore. bioRxiv"},{"issue":"1","key":"pone.0272954.ref008","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13059-018-1618-7","article-title":"An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar","volume":"20","author":"ND Grubaugh","year":"2019","journal-title":"Genome Biol"},{"key":"pone.0272954.ref009","first-page":"468","article-title":"Detecting rare structural variation in evolving microbial populations from new sequence junctions using breseq","volume":"5","author":"DE Deatherage","year":"2014","journal-title":"Front Genet"},{"issue":"2","key":"pone.0272954.ref010","doi-asserted-by":"crossref","first-page":"veab064","DOI":"10.1093\/ve\/veab064","article-title":"Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool.","volume":"7","author":"A O\u2019Toole","year":"2021","journal-title":"Virus Evol"},{"issue":"4","key":"pone.0272954.ref011","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/molbev\/mst010","article-title":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability","volume":"30","author":"K Katoh","year":"2013","journal-title":"Mol Biol Evol"},{"issue":"1","key":"pone.0272954.ref012","doi-asserted-by":"crossref","first-page":"vex042","DOI":"10.1093\/ve\/vex042","article-title":"TreeTime: Maximum-likelihood phylodynamic analysis","volume":"4","author":"P Sagulenko","year":"2018","journal-title":"Virus Evol"},{"issue":"1","key":"pone.0272954.ref013","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12864-022-08652-z","article-title":"SARS-CoV-2 Delta variant isolates from vaccinated individuals","volume":"23","author":"L Brinkac","year":"2022","journal-title":"BMC Genomics"},{"issue":"40","key":"pone.0272954.ref014","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.15585\/mmwr.mm7040a4","article-title":"Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System\u2014California, March-July 2021.","volume":"70","author":"DE Malden","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"43","key":"pone.0272954.ref015","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.15585\/mmwr.mm7043e1","article-title":"Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance\u2014COVID-NET, 14 States, January-August 2021.","volume":"70","author":"CA Taylor","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pone.0272954.ref016","article-title":"Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas","author":"PA Christensen","year":"2021","journal-title":"Am J Pathol"},{"issue":"2","key":"pone.0272954.ref017","doi-asserted-by":"crossref","DOI":"10.3201\/eid2802.211789","article-title":"Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants","volume":"28","author":"I Kislaya","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"24","key":"pone.0272954.ref018","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1056\/NEJMoa2114228","article-title":"Waning Immunity after the BNT162b2 Vaccine in Israel","volume":"385","author":"Y Goldberg","year":"2021","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0272954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T17:34:28Z","timestamp":1661967268000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0272954"}},"subtitle":[],"editor":[{"given":"Cecilio","family":"L\u00f3pez-Gal\u00edndez","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,31]]},"references-count":18,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0272954","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2022,8,31]]}}}